Home > Journals > Medicine > Hématologie > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Hématologie
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Factor XI deficiency


Hématologie. Volume 16, Number 4, 284-92, juillet-août 2010, Revue

Résumé   Article gratuit  

Author(s) : Emmanuelle de Raucourt, Frédéric Bauduer, Brigitte Pan-Petesch, Jenny Goudemand

Summary : FXI deficiency is a rare bleeding disorder which has a particularly high incidence among Ashkenazi Jews. FXI deficiency is a mild bleeding disorder associated with site injury bleeding typically involving tissue at high fibrinolytic activity. Replacement therapy either with fresh frozen plasma or a factor XI concentrate is the mainstay of therapy. The poor correlation between FXI levels and the bleeding phenotype, the variability of the bleeding diathesis even in the same patient, and the potential complications of the treatments have caused difficulty in formulating concrete treatment recommendations. This review gives an overview of the structure, and the role of FXI in the coagulation pathway, the pathophysiology, the genetic basis, the clinical manifestations and the management of FXI deficiency.

Keywords : factor XI deficiency, factor XI, rare bleeding disorder

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]